phenylalanine has been researched along with Diabetic Neuropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedenberg, FK; Piech, G; Reichenbach, ZW; Selby, A | 1 |
| Ito, S; Kitahara, Y; Mine, T; Miura, K; Takesue, K; Uchida, Y; Wada, R; Yagihashi, S | 1 |
| Allawi, J; Worsley, AP | 1 |
| Bourre, JM; Fournier, E; Fournier, LE; Lecorsier, A | 1 |
1 review(s) available for phenylalanine and Diabetic Neuropathies
| Article | Year |
|---|---|
Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea.
Topics: Antidiarrheals; Autonomic Nervous System Diseases; Blind Loop Syndrome; Celiac Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diagnosis, Differential; Diarrhea; Diphenoxylate; Enteric Nervous System; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Gastrointestinal Motility; Hypoglycemic Agents; Imidazoles; Inflammation; Inflammatory Bowel Diseases; Interstitial Cells of Cajal; Intestinal Absorption; Intestinal Mucosa; Irritable Bowel Syndrome; Loperamide; Neuroglia; Non-Nutritive Sweeteners; Oxidative Stress; Phenylalanine; Serotonin 5-HT3 Receptor Antagonists | 2019 |
3 other study(ies) available for phenylalanine and Diabetic Neuropathies
| Article | Year |
|---|---|
Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes.
Topics: Animals; Area Under Curve; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glyburide; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Nateglinide; Phenylalanine; Postprandial Period; Rats; Rats, Inbred Strains; Rats, Wistar; Sciatic Nerve; Time Factors | 2002 |
A combined treatment for severe diabetic neuropathy symptoms.
Topics: Adult; Antidepressive Agents, Tricyclic; Diabetic Neuropathies; Drug Therapy, Combination; Hematinics; Humans; Lofepramine; Male; Middle Aged; Phenylalanine; Vitamin B 12 | 1998 |
[Lymphocyte phenylvaleric acid hydroxylase activity (L-PVH), a new marker of peripheral neurotoxicity].
Topics: Adult; Biomarkers; Carboxylic Ester Hydrolases; Diabetic Neuropathies; Humans; Lymphocytes; Mixed Function Oxygenases; Peripheral Nervous System Diseases; Phenylalanine; Valerates | 1992 |